Allergy center was opened in Hadassah Medical Moscow, first participant of the International medical cluster. During the opening ceremony participants discussed what opportunities the new center will give to Russian doctors and patients.
Allergology is becoming more in demand – according to WHO, the number of people suffering from allergic diseases increased by 20% from 2001 to 2010, and by 2025 they will be 50% of the world's population. Allergy is an urgent problem particularly in large cities – even in Moscow, which has great number of green areas and public parks, the increase in the incidence is 10-15% annually.
"In view of the growing problem, it is especially important to increase the expertise of the Moscow allergy and immunology specialists. The Allergy center at Hadassah Medical Moscow will allow patients to receive high-quality diagnostics and treatment using innovative drugs and technologies. Moreover, Russian specialists will have an opportunity to exchange experience with foreign colleagues", said Ildar Khayrullin, General Director of the IMC Foundation.
"The management of the Hadassah Medical Moscow believes that the allergology is one of the most perspective direction of Diagnostics center activity. The Israeli hospital Hadassah is actively involved in the development of this field in the Moscow branch. On the territory of the International Medical Cluster, patients and doctors will have access to the latest methods of diagnosis and therapy, which will give people with allergic diseases the opportunity to live a full life, " said Tatyana Zhelninova, Deputy head of the Hadassah Medical Moscow.
At the opening ceremony guests had the opportunity to discuss innovations in allergology, changes in the process of diagnosis and treatment of autoimmune and allergic diseases in recent years and new challenges with experts of the Israeli clinic Hadassah, Yuval Tal, MD, the director of Allergy and Clinical Immunology Unit and the director of Occupational Health Unit, and Alon Hershko, MD, head of the therapeutic Department of the University hospital of Hadassah in Jerusalem. Also, leading Russian experts participated in the discussion: Daria Fomina, MD, PhD, head of Moscow Center of Allergy and Immunology, City Clinical Hospital № 52, Alexander Pampura, MD, head of Department of Allergology and Clinical Immunology Of Pediatric Research Institute of Pirogov Russian National Research Medical University and Elena Borzova, Professor of skin and venereal diseases faculty of I.M. Sechenov First Moscow State Medical University.
The allergy center will specialize in the diagnosis and treatment of respiratory, food, drug, insect allergies, anaphylaxis, diseases mediated by eosinophils, as well as allergic skin reactions — more than 50% of patients are people with atopic, contact dermatitis and urticaria.
The international allergy center will use immunotherapy, biological drugs and a desensitization, a method that has proven its effectiveness, but is not practiced in Russia.
During the discussion of the state of allergology in Russia and Israel, leading Moscow specialists affirmed the need of the center's establishment. According to Daria Fomina, the situation with the availability of medicines in Moscow is stable, unlike in more remote areas, but there is still a need for additional diagnostic and treatment tools. Alexander Pampura supported his colleague, stressing that the choice of drugs should become even wider. Speaking about the diagnosis of allergic diseases, the expert emphasized that Russia does not have a large number of diagnostic portfolios for detecting an allergic reaction to a particular stimulus. Elena Borzova noted that the doctor himself plays an equally important role in diagnosis and treatment, therefore, it is extremely important for Israeli specialists not only to provide access to new medicines, but also to conduct training workshops for Russian colleagues and familiarize them with the guidelines.